BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17355424)

  • 21. Incidence rate of mycosis fungoides in Isfahan (Iran).
    Salehi M; Azimi Z; Fatemi F; Rajabi P; Kazemi M; Amini G
    J Dermatol; 2010 Aug; 37(8):703-7. PubMed ID: 20649711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.
    Marsella R; Olivry T; Carlotti DN;
    Vet Dermatol; 2011 Jun; 22(3):239-48. PubMed ID: 21414049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression in canine atopic dermatitis and correlation with clinical severity scores.
    Wood SH; Clements DN; Ollier WE; Nuttall T; McEwan NA; Carter SD
    J Dermatol Sci; 2009 Jul; 55(1):27-33. PubMed ID: 19394200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nontraditional treatment of mycosis fungoides in a dog.
    Bender WM
    J Am Vet Med Assoc; 1984 Oct; 185(8):900-1. PubMed ID: 6501050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is your diagnosis? Erythroderma form of mycosis fungoides.
    Nuttall T
    J Small Anim Pract; 1997 Nov; 38(11):487, 519. PubMed ID: 9403806
    [No Abstract]   [Full Text] [Related]  

  • 26. Altered cutaneous expression of beta-defensins in dogs with atopic dermatitis.
    van Damme CM; Willemse T; van Dijk A; Haagsman HP; Veldhuizen EJ
    Mol Immunol; 2009 Aug; 46(13):2449-55. PubMed ID: 19576634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dupilumab-associated mycosis fungoides: a cross-sectional study.
    Hamp A; Hanson J; Schwartz RA; Lambert WC; Alhatem A
    Arch Dermatol Res; 2023 Nov; 315(9):2561-2569. PubMed ID: 37270763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of HECA-452 in parapsoriasis and mycosis fungoides.
    Di Trolio R; Di Lorenzo G; Barbiero E; Iacono A; Franco R; D Armiento M; Delfino M; D Armiento FP
    Int J Immunopathol Pharmacol; 2006; 19(1):105-10. PubMed ID: 16569348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canine cutaneous lymphoma.
    McKeever PJ; Grindem CB; Stevens JB; Osborne CA
    J Am Vet Med Assoc; 1982 Mar; 180(5):531-6. PubMed ID: 7061338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Owner assessment of therapeutic interventions for canine atopic dermatitis: a long-term retrospective analysis.
    Dell DL; Griffin CE; Thompson LA; Griffies JD
    Vet Dermatol; 2012 Jun; 23(3):228-e47. PubMed ID: 22575021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of commercially available veterinary diets recommended for dogs with atopic dermatitis.
    Glos K; Linek M; Loewenstein C; Mayer U; Mueller RS
    Vet Dermatol; 2008 Oct; 19(5):280-7. PubMed ID: 18699815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intradermal testing with the storage mite Tyrophagus putrescentiae in normal dogs and dogs with atopic dermatitis in Colorado.
    Mueller RS; Fieseler KV; Rosychuk RA; Greenwalt T
    Vet Dermatol; 2005 Feb; 16(1):27-31. PubMed ID: 15725102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staphylococcal colonization of mucosal and lesional skin sites in atopic and healthy dogs.
    Fazakerley J; Nuttall T; Sales D; Schmidt V; Carter SD; Hart CA; McEwan NA
    Vet Dermatol; 2009 Jun; 20(3):179-84. PubMed ID: 19392768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple, resolving, cutaneous histiocytoma in a dog.
    Bender WM; Muller GH
    J Am Vet Med Assoc; 1989 Feb; 194(4):535-7. PubMed ID: 2537810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The spatial distribution of atopic dermatitis cases in a population of insured Swedish dogs.
    Nødtvedt A; Guitian J; Egenvall A; Emanuelson U; Pfeiffer DU
    Prev Vet Med; 2007 Mar; 78(3-4):210-22. PubMed ID: 17112611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral measurement of type-1 hypersensitivity reactions to a commercial Malassezia allergen.
    Farver K; Morris DO; Shofer F; Esch B
    Vet Dermatol; 2005 Aug; 16(4):261-8. PubMed ID: 16101797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a topically applied preparation of epidermal lipids on the stratum corneum barrier of atopic dogs.
    Piekutowska A; Pin D; Rème CA; Gatto H; Haftek M
    J Comp Pathol; 2008 May; 138(4):197-203. PubMed ID: 18374938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene (mRNA) expression in canine atopic dermatitis: microarray analysis.
    Merryman-Simpson AE; Wood SH; Fretwell N; Jones PG; McLaren WM; McEwan NA; Clements DN; Carter SD; Ollier WE; Nuttall T
    Vet Dermatol; 2008 Apr; 19(2):59-66. PubMed ID: 18336422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycosis fungoides masquerading as cutaneous lupus erythematosus and associated with antiphospholipid syndrome.
    Veysey EC; Wilkinson JD
    Clin Exp Dermatol; 2008 Jan; 33(1):26-9. PubMed ID: 17979989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early-stage mycosis fungoides, parapsoriasis en plaque, and pregnancy.
    Amitay-Layish I; David M; Kafri B; Barzilai A; Feinmesser M; Hodak E
    Int J Dermatol; 2007 Feb; 46(2):160-5. PubMed ID: 17269968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.